farmakologi

8
Current strategies Anti-malaria for pregnant women

description

farmako

Transcript of farmakologi

Page 1: farmakologi

Current strategies

Anti-malaria for pregnant women

Page 2: farmakologi

Options for malaria control during pregnancy

• Drugs– Chemoprophylaxis

– Intermittent preventive treatment during pregnancy (IPTp)

– Febrile case management• Insecticide Treated Nets (ITNs)• Prevention and treatment of anemia

– Hematinic supplementation– Nutritional counseling

• Vaccines?

Page 3: farmakologi

Intermittent preventive treatment (IPTp): an alternative strategy

• Most studied regimen: Sulfadoxine-pyrimethamine (SP) 2 curative courses (3 tablets)– One course during second trimester– One course during third trimester

• Inexpensive• Easily deliverable (can be given under direct

observation)• Safe• Efficacious

Page 4: farmakologi

Intermittent preventive treatment-- the two dose SP strategy

Weeks of gestation

Conception Birth

20 3010

Course 124-28 wks

Course 230-36 wks

Fetal growth velocity

Page 5: farmakologi

IPTp with SP: summary of evidence and benefits

• 2 doses of IPT with SP is associated with: – Reduction in 3rd trimester maternal

anemia – Reduction in placental malaria

parasitemia– Reduction in low birth weight

• At least 2 doses required for optimal benefit

• Regimen is safe and well tolerated

Page 6: farmakologi

Case management of malaria in pregnancy

Safe drugs

• Chloroquine• Quinine / quinidine • Proguanil, chlorproguanil• Pyrimethamine• Sulfonamides• Dapsone (+pyrimethamine=

Maloprim)• Mefloquine (prophylaxis)• Clindamycin (300 mg qid, 5-7

days)• Artemisinins (2nd and 3rd)

Drugs with questionable safety or insufficient data

• Mefloquine (treatment dose)• Artemisinins (1st)• Amodiaquine• Azithromycin• Lumefantrine (component of

coartem/Riamet)• Combination therapy

– Artemisinin derivative with other drugs

– Lapdap (chlorproguanil-dapsone)

– Atovaquone-proguanil (Malarone)

– Amodiaquine-SP

Page 7: farmakologi

Anti-malarials contra-indicated in pregnancy

• Tetracycline• Doxycycline• Halofantrine• Primaquine• Tafenoquine• Note: if serious illness, and where limited

number of drugs are available, it is necessary to balance the risk of maternal death with the hypothetical risks to the infant

Page 8: farmakologi

Drugs that should not be used during pregnancy

• Tetracycline– Cause abnormalities of skeletal and muscular growth,

tooth development, lens/cornea• Doxycycline

– Risk of cosmetic staining of primary teeth is undetermined

– Excreted into breast milk• Primaquine

– Harmful to newborns who are relatively Glucose-6-Phosphatase-Dehydrogenase (G6PD) deficient

• Halofantrine– No conclusive studies in pregnant women– Has been shown to cause unwanted effects, including

death of the fetus, in animals